Which Risk Score Best Assesses Clinical Objectives in Patients with Hypertrophic Cardiomyopathy?
- PMID: 32876185
- PMCID: PMC8384274
- DOI: 10.36660/abc.20200543
Which Risk Score Best Assesses Clinical Objectives in Patients with Hypertrophic Cardiomyopathy?
Comment on
-
Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.Arq Bras Cardiol. 2020 Aug 28;115(2):197-204. doi: 10.36660/abc.20190161. Arq Bras Cardiol. 2020. PMID: 32876184 Free PMC article. English, Portuguese.
References
-
- 3. Pare JA, Fraser RG, Pirozynski WJ, Shanks JA, Stubington D. “Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy”. Am J Med. 31: 37–62.. - PubMed
-
- 5. Brock R. “Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis)”. Guys Hosp Rep.1959;108:126-43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
